SCHEMBL21748039

SCHEMBL21748039

COc1cccc(-c2nnc(NS(=O)(=O)C(C)C(OC)c3ncc(C)cn3)n2-c2c(OC)ncnc2OC)n1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APLNR P35414 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30134667 1.00 APLNR (1.00) APLNR
SCHEMBL18246522 1.00 APLNR (1.00) APLNR
SCHEMBL18257262 0.95 APLNR (0.91) APLNR
SCHEMBL18246462 0.93 APLNR (1.00) APLNR
SCHEMBL18519126 0.92 APLNR (0.85) APLNR
SCHEMBL18519159 0.92 APLNR (0.85) APLNR
SCHEMBL28459733 0.91 APLNR (1.00) APLNR
SCHEMBL18247248 0.91 APLNR (1.00) APLNR
SCHEMBL18246554 0.91 APLNR (1.00) APLNR
SCHEMBL21748033 0.91 APLNR (1.00) APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3300500-B9 TRIAZOLE AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2021-01-13 EP claimed
EP-3300500-B1 TRIAZOLE AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2020-02-26 EP claimed
EP-4532015-A1 APELIN RECEPTOR MODULATORS FOR TREATMENT OF A DISORDER OR DISEASE ASSOCIATED WITH BBB PERMEABILITY Bioage Labs, Inc. (US) 2025-04-09 EP disclosed
EP-4319873-A1 APELIN RECEPTOR MODULATORS FOR TREATING AGE-RELATED MUSCLE CONDITIONS Bioage Labs, Inc. (US) 2024-02-14 EP disclosed
WO-2023235360-A1 APELIN RECEPTOR MODULATORS FOR TREATMENT OF A DISORDER OR DISEASE ASSOCIATED WITH BBB PERMEABILITY BioAge Labs, Inc. (US) 2023-12-07 WO disclosed